Animal embryos as a model for in vivo screening of antiangiogenic drugs
Protocols
Animal embryos as a model for in vivo screening of antiangiogenic drugs
·Reviewed·Published ·Updated ·8 min read
Summary
At the early stage of angiogenesis in the chick embryo chorionic allantoic membrane, the immune system of the organism is not yet fully established, and therefore almost no rejection of various foreign substances occurs, which facilitates the placing of drug-containing carriers on its surface and the observation of the effects of various inducers and inhibitors on angiogenesis.
For more product details, please visit Aladdin Scientificwebsite.
Da — when not otherwise indicated, molecular weight units are daltons. Mw — weight-average molecular weight. Mn — number-average molecular weight.
Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.
Cite this article
Aladdin Scientific. "Animal embryos as a model for in vivo screening of antiangiogenic drugs" Aladdin Knowledge Base, updated Dec 24, 2024. https://www.aladdinsci.com/us_en/faqs/animal-embryos-as-a-model-for-in-vivo-sc-en.html
Was this article helpful?YesNo0 out found this helpful
We use cookies to ensure the website functions properly and, where permitted, to improve your experience. You can manage your preferences at any time in Settings. Learn more in our Cookie Policy.
Shall we send you a message when we have discounts available?
Remind me later
Thank you! Please check your email inbox to confirm.
Products are supplied to verified businesses, institutions, and qualified professionals for research and development use only. Not for use in humans, animals, diagnosis, or therapy.
